Skip to main content
. 2020 Apr 23;10(4):245. doi: 10.3390/diagnostics10040245
ESRD end-stage renal disease
RRT renal replacement therapy
CKD chronic kidney disease
TSH thyroid-stimulating hormone
FT3 free triiodothyronine
FT4 free thyroxin
US ultrasonography
CKD-MBD chronic kidney disease mineral bone disorder
GFR glomerular filtration rate
RPF renal plasma flow
TG Ab thyroglobulin antibodies
TPO Ab thyroperoxidase antibodies